INS and Hypoglycemia: As in other studies of type 1 diabetes and metformin, HbA1c was only transiently improved by metformin and reverted to baseline over the first 6 months of use, probably as insulin doses were down-titrated by patients in an effort to avoid hypoglycaemia [9].